Zolpidem modified-release 12.5 mg improves measures of sleep continuity in a model of sleep disturbance (traffic noise) compared with standard zolpidem 10 mg.

被引：0

作者：

Stanley, N

Hindmarch, I

Legangeux, E

Emegbo, S

机构：

[1] Univ Surrey, HPRU Med Res Ctr, Guildford GU2 5XH, Surrey, England

[2] Sanofi Aventis Res, Malvern, PA USA

来源：

PHARMACOTHERAPY | 2005年 / 25卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1483 / 1483

页数：1

共 11 条

[1] Zolpidem modified-release objectively and subjectively improves sleep maintenance and retains the characteristics of standard zolpidem on sleep initiation and duration in elderly patients with primary insomnia
Roehrs, TA
Soubrane, C
Roth, T
[J]. SLEEP, 2005, 28 : A244 - A244
[2] Zolpidem modified-release significantly reduces latency to persistent sleep 4 and 5 hours postdose compared with standard zolpidem in a model assessing the return to sleep following nocturnal awakening
Hindmarch, I
Stanley, N
Legangneux, E
Emegbo, S
[J]. SLEEP, 2005, 28 : A245 - A246
[3] Pharmacokinetic profile of a new modified-release formulation of zolpidem designed to improve sleep continuity
Dubruc, C.
Weinling, E.
Andre, F.
[J]. JOURNAL OF SLEEP RESEARCH, 2006, 15 : 196 - 196
[4] A randomized double-blind placebo-controlled 10-way crossover study to show that a new zolpidem modified-release formulation improves sleep maintenance compared to standard zolpidem.
Hindmarch, I
Legangeux, E
Emegbo, S
Nixon, A
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P26 - P26
[5] A randomised double-blind placebo-controlled 10-way cross-over study shows that a new zolpidem modified-release formulation improves sleep maintenance compared to standard zolpidem
Hindmarch, I
Legangneux, E
Stanley, N
[J]. SLEEP, 2004, 27 : 55 - 55
[6] Zolpidem modified-release 12.5 mg has no residual effects on psychomotor performance and cognitive function in healthy adult subjects
Blin, O
Micallef-Rolle, J
Legangneux, E
Zobouyan, F
[J]. SLEEP, 2005, 28 : A246 - A246
[7] Zolpidem modified-release improves sleep induction, sleep maintenance, sleep duration, and quality of sleep without next-day residual effects in adults with primary insomnia
Soubrane, C
Walsh, J
Roth, T
[J]. SLEEP, 2005, 28 : A244 - A245
[8] Zolpidem extended-release 12.5-mg, taken for 24 weeks "as needed" up to 7 nights/week, improves subjective measures of therapeutic global impression, sleep onset, and sleep maintenance in patients with chronic insomnia
Erman, M.
Krystal, A.
Zammit, G.
Soubrane, C.
Roth, T.
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S256 - S256
[9] Zolpidem modified-release 6.25 mg and double dose 12.5 mg have no residual effects on central nervous system integrative capacity, sensorimotor and psychomotor performance, and immediate and delayed memory recall in healthy elderly subjects
Legangneux, E
Hindmarch, I
Zobouyan, I
[J]. SLEEP, 2005, 28 : A245 - A245
[10] A placebo controlled, randomised, double-blind, 4 way cross-over study of 3 doses of EVT201 (2.5mg, 5mg and 10mg) on aspects of sleep and morning after performance using a traffic noise model of sleep disturbance
Stanley, N.
Boyle, J.
Hunneyball, I
Kemp, J.
Nicholson, A.
[J]. SLEEP, 2006, 29 : A255 - A255

← 1 2 →